Nurx’s Merger with Thirty Madison

Fenwick & West and Jones Day advised Nurx on the deal while Cooley and Foley & Lardner LLP advised Thirty Madison.

Nurx, a female-focused digital healthcare company, announced its definitive agreement to merge with Thirty Madison, a specialty healthcare company for people living with chronic conditions, under the Thirty Madison brand.

The partnership will allow for greater access to care on a single, unified platform, while rapidly accelerating the use of Thirty Madison’s specialist-level care model through a breadth of new condition offerings, as well as a broader reach of patients through employers and payors via innovative partnerships.

The Fenwick transaction team for Nurx’s merger was led by Michael Esquivel (Picture) and included corporate partners Kris Withrow and Michael Esquivel and associates Ryan McRobert, Will Black, David Heckman and Zoe Zhang; executive compensation and employee benefits partner Shawn Lampron, counsel Jane Piehler and associates Bryan Belok and Cynthia Yuan; technology transactions partner David Hayes and associate Jefferson Lin; regulatory partner Mark Ostrau; and tax partner Julia Ushakova-Stein and associate Mike Knobler.

Partners Ian Nussbaum and Adam Dinow led the Cooley team advising Nurx. Additional assistance was provided by Brian Kloeblen, Amanda Griggs, Eileen Marshall, Joshua Friedman, Len Jacoby, Robert Sanchez, Patrick Flanagan, Gerard O’Shea, Terry Kim, Michael Coburn, Scott D. Rudin, Nathan Baum, DeVon Barnett, Howard Morse, Mor Agam, Jessica Winn, Dov Fiskus, Jane Jeong, Patrick Johnson, Alex Leavy, Amis Pan, Chris Chynoweth, Patricia A. Myers and Nitasha Bennett.

The Jones Day team was led by Alexis Gilroy and Jennifer Everett.

The Foley deal team was led by Partners Kyle Faget and Nathaniel Lacktman and included Senior Counsel Aaron Maguregui and Associates Allie Shalom, Andrew Kuder, Stephanie Schwartz, Olivia King, and Jessa Boubker.

Involved fees earner: Mor Agam – Cooley LLP; DeVon Barnett – Cooley LLP; Nathan Baum – Cooley LLP; Chris Chynoweth – Cooley LLP; Michael Coburn – Cooley LLP; Adam Dinow – Cooley LLP; Dov Fiskus – Cooley LLP; Patrick Flanagan – Cooley LLP; Joshua Friedman – Cooley LLP; Amanda Griggs – Cooley LLP; Len Jacoby – Cooley LLP; Jane Jeong – Cooley LLP; Patrick Johnson – Cooley LLP; Terry Kim – Cooley LLP; Brian Kloeblen – Cooley LLP; Alexandra Leavy – Cooley LLP; Eileen Marshall – Cooley LLP; Howard Morse – Cooley LLP; Ian Nussbaum – Cooley LLP; Gerard O’Shea – Cooley LLP; Amis Pan – Cooley LLP; Scott Rudin – Cooley LLP; Robert Sanchez – Cooley LLP; Jessica Winn – Cooley LLP; Bryan Belok – Fenwick & West LLP; Will Black – Fenwick & West LLP; Michael Esquivel – Fenwick & West LLP; David Hayes – Fenwick & West LLP; David Heckman – Fenwick & West LLP; Michael Knobler – Fenwick & West LLP; Shawn Lampron – Fenwick & West LLP; Jefferson Lin – Fenwick & West LLP; Ryan McRobert – Fenwick & West LLP; Mark Ostrau – Fenwick & West LLP; Julia Ushakova-Stein – Fenwick & West LLP; Kris Withrow – Fenwick & West LLP; Cynthia Yuan – Fenwick & West LLP; Jessa Boubker – Foley & Lardner LLP; Kyle Faget – Foley & Lardner LLP; Olivia King – Foley & Lardner LLP; Andrew Kuder – Foley & Lardner LLP; Nathaniel Lacktman – Foley & Lardner LLP; Aaron Maguregui – Foley & Lardner LLP; Stephanie Schwartz – Foley & Lardner LLP; Jennifer Everet – Jones Day; Alexis Gilroy – Jones Day;

Law Firms: Cooley LLP; Fenwick & West LLP; Foley & Lardner LLP; Jones Day;

Clients: Nurx Inc.; Thirty Madison;

Martina Bellini

Author: Martina Bellini